Beyond efficacy: pharmacokinetic differences between clopidogrel, prasugrel and ticagrelor.
about
Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety.Effect of CYP3A4∗1G and CYP3A5∗3 Polymorphisms on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Subjects.The role of pharmacogenetics in nonmalignant gastrointestinal diseases.Prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome: matching treatments with patients.Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome.Acute coronary syndromes: advances in antithrombotics.Prasugrel suppresses development of lithium-induced nephrogenic diabetes insipidus in mice.Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina.4-Benzothiazole-7-hydroxyindolinyl diaryl ureas are potent P2Y1 antagonists with favorable pharmacokinetics: low clearance and small volume of distribution.Cytochrome P450 and Non-Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics.Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome.
P2860
Q34805121-246D647F-85A1-469F-BEDF-323AD762B2DFQ37730915-B3D9C617-8C88-4332-958A-6C1EF750039DQ37981892-EBF5389E-0568-4956-BC83-531124736D90Q37982427-6819CE89-BE0D-4187-815B-6B99986396E3Q37990848-FCA57BE5-09E2-44E7-9D0D-75EC4C3271EEQ38086096-DCD40837-3BE2-4DDA-A830-8C5119BEB4EEQ38944892-D8E5FB6C-664A-4CF4-B476-BD21093CE695Q39449665-46E466FC-2F65-4425-B07E-092CFC600D96Q45369986-70CC8064-85B2-4F0C-A220-6028C44A33CDQ46076879-7C7A8D98-376D-40BB-8FD8-FDE3C343D245Q48774020-58DAAEE0-32E3-4C68-A31F-9F70EC3B8EC2
P2860
Beyond efficacy: pharmacokinetic differences between clopidogrel, prasugrel and ticagrelor.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Beyond efficacy: pharmacokinet ...... rel, prasugrel and ticagrelor.
@en
Beyond efficacy: pharmacokinet ...... rel, prasugrel and ticagrelor.
@nl
type
label
Beyond efficacy: pharmacokinet ...... rel, prasugrel and ticagrelor.
@en
Beyond efficacy: pharmacokinet ...... rel, prasugrel and ticagrelor.
@nl
prefLabel
Beyond efficacy: pharmacokinet ...... rel, prasugrel and ticagrelor.
@en
Beyond efficacy: pharmacokinet ...... rel, prasugrel and ticagrelor.
@nl
P2093
P2860
P1476
Beyond efficacy: pharmacokinet ...... grel, prasugrel and ticagrelor
@en
P2093
Guillermo Di Girolamo
Hernán Cohen Arazi
Mariano A Giorgi
P2860
P304
P356
10.1517/14656566.2011.550573
P407
P50
P577
2011-01-22T00:00:00Z